← All organizations

Nile Therapeutics

For profit

Also known as: Nile Therapeutics Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

May 1, 2011

Acquired by Capricor Inc. on Nov 20, 2013

Timeline

2000s

Jun 1, 2005
Nile Therapeutics— Founded

2010s

Nov 20, 2013
Capricor Inc.— Acquired By

Drugs by trial phase (2 distinct, 5 trials)

Phase 2 (1 own, 0 via acquisition)

chimeric natriuretic peptide

Phase 1 (1 own, 0 via acquisition)

cenderitide

Indications

Studied for

Heart Failure

Recent trials (7)

NCT01316432Lead sponsorPhase 1May 1, 2011
NCT00839007Study directorPhase 2Jun 1, 2009
NCT00839007Lead sponsorPhase 2Jun 1, 2009
NCT00699712Lead sponsorPhase 2Jun 1, 2008
NCT00699712Study directorPhase 2Jun 1, 2008
NCT00557661Lead sponsorPhase 1Nov 1, 2007
NCT00482937Lead sponsorPhase 1Jan 1, 2007

Details

Founded: San Mateo, CA, US Jun 1, 2005
Last known activity: May 1, 2011